Suppr超能文献

用于初级保健和社区环境的多种疾病和发病负担的衡量标准:系统评价和指南。

Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide.

机构信息

Academic Unit of Primary Health Care, School of Social and Community Medicine, Bristol University, Bristol, England.

出版信息

Ann Fam Med. 2012 Mar-Apr;10(2):134-41. doi: 10.1370/afm.1363.

Abstract

PURPOSE

Many patients consulting in primary care have multiple conditions (multimorbidity). Aims of this review were to identify measures of multimorbidity and morbidity burden suitable for use in research in primary care and community populations, and to investigate their validity in relation to anticipated associations with patient characteristics, process measures, and health outcomes.

METHODS

Studies were identified using searches in MEDLINE and EMBASE from inception to December 2009 and bibliographies.

RESULTS

Included were 194 articles describing 17 different measures. Commonly used measures included disease counts (n = 98), Chronic Disease Score (CDS)/RxRisk (n = 17), Adjusted Clinical Groups (ACG) System (n = 25), the Charlson index (n = 38), the Cumulative Index Illness Rating Scale (CIRS; n = 10) and the Duke Severity of Illness Checklist (DUSOI; n = 6). Studies that compared measures suggest their predictive validity for the same outcome differs only slightly. Evidence is strongest for the ACG System, Charlson index, or disease counts in relation to care utilization; for the ACG System in relation to costs; for Charlson index in relation to mortality; and for disease counts or Charlson index in relation to quality of life. Simple counts of diseases or medications perform almost as well as complex measures in predicting most outcomes. Combining measures can improve validity.

CONCLUSIONS

The measures most commonly used in primary care and community settings are disease counts, Charlson index, ACG System, CIRS, CDS, and DUSOI. Different measures are most appropriate according to the outcome of interest. Choice of measure will also depend on the type of data available. More research is needed to directly compare performance of different measures.

摘要

目的

在初级保健中就诊的许多患者患有多种疾病(共病)。本研究旨在确定适用于初级保健和社区人群研究的共病和发病负担测量方法,并调查它们与预期的患者特征、过程指标和健康结果之间的相关性的有效性。

方法

使用 MEDLINE 和 EMBASE 从建立到 2009 年 12 月的搜索以及参考文献进行研究。

结果

共纳入了 194 篇描述 17 种不同方法的文章。常用的方法包括疾病计数(n=98)、慢性疾病评分(CDS)/RxRisk(n=17)、调整临床分组系统(ACG)(n=25)、Charlson 指数(n=38)、累积疾病严重程度评分量表(CIRS;n=10)和杜克严重疾病检查表(DUSOI;n=6)。比较这些方法的研究表明,它们对同一结果的预测效度差异很小。ACG 系统、Charlson 指数或疾病计数与医疗利用的关系最有力;ACG 系统与成本的关系;Charlson 指数与死亡率的关系;疾病计数或 Charlson 指数与生活质量的关系。疾病或药物的简单计数在预测大多数结果方面几乎与复杂方法一样有效。结合使用这些方法可以提高有效性。

结论

在初级保健和社区环境中最常用的方法是疾病计数、Charlson 指数、ACG 系统、CIRS、CDS 和 DUSOI。根据感兴趣的结果,选择最合适的方法。测量方法的选择还取决于可用数据的类型。需要更多的研究来直接比较不同方法的性能。

相似文献

2
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.
Cochrane Database Syst Rev. 2016 Mar 14;3(3):CD006560. doi: 10.1002/14651858.CD006560.pub3.
3
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006560. doi: 10.1002/14651858.CD006560.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Evaluating common outcomes for measuring treatment success for chronic low back pain.
Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S54-68. doi: 10.1097/BRS.0b013e31822ef74d.
8
Interventions for interpersonal communication about end of life care between health practitioners and affected people.
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

3
Measuring self-efficacy in U.S. older adults with chronic disease: a systematic review.
Aging Ment Health. 2025 Jun 16:1-10. doi: 10.1080/13607863.2025.2511226.
6
Sex-Specific Multimorbidity-Multibehaviour Patterns in Primary Care Populations.
Int J Environ Res Public Health. 2025 Mar 24;22(4):485. doi: 10.3390/ijerph22040485.
8
Multimorbidity and analgesic-related harms: a systematic review.
Br J Anaesth. 2025 Jun;134(6):1717-1745. doi: 10.1016/j.bja.2025.02.012. Epub 2025 Mar 20.

本文引用的文献

1
Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study.
Br J Gen Pract. 2011 Jan;61(582):e12-21. doi: 10.3399/bjgp11X548929.
2
The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices.
J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):301-11. doi: 10.1093/gerona/glq208. Epub 2010 Nov 26.
3
Defining comorbidity: implications for understanding health and health services.
Ann Fam Med. 2009 Jul-Aug;7(4):357-63. doi: 10.1370/afm.983.
4
Validity of medication-based co-morbidity indices in the Australian elderly population.
Aust N Z J Public Health. 2009 Apr;33(2):126-30. doi: 10.1111/j.1753-6405.2009.00357.x.
5
Impact of age and comorbidity on colorectal cancer screening among older veterans.
Ann Intern Med. 2009 Apr 7;150(7):465-73. doi: 10.7326/0003-4819-150-7-200904070-00006.
6
Analysis of multimorbidity in individual elderly nursing home residents. Development of a multimorbidity matrix.
Arch Gerontol Geriatr. 2009 Nov-Dec;49(3):413-9. doi: 10.1016/j.archger.2008.12.009. Epub 2009 Jan 29.
7
Seniors' self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures.
J Clin Epidemiol. 2009 May;62(5):550-7.e1. doi: 10.1016/j.jclinepi.2008.05.002. Epub 2008 Aug 30.
8
The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients.
J Clin Epidemiol. 2008 Dec;61(12):1234-1240. doi: 10.1016/j.jclinepi.2008.01.006. Epub 2008 Jul 10.
9
Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population.
Stroke. 2008 Jul;39(7):1938-44. doi: 10.1161/STROKEAHA.107.504688. Epub 2008 Apr 24.
10
Comorbidity index was successfully validated among men but not in women.
J Clin Epidemiol. 2008 Aug;61(8):796-802. doi: 10.1016/j.jclinepi.2007.09.006. Epub 2008 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验